Beckman Coulter, Inc.

Beckman Coulter – Access Interleukin-6 (IL-6)

Highlights: 

The Access Interleukin-6 (IL-6) assay is a fully automated immunoassay designed to measure the IL-6 level in serum and plasma which can be used to assist in identifying severe inflammatory response in patients with confirmed COVID-19 illness to aid in determining the risk of intubation with mechanical ventilation, in conjunction with clinical findings and the results of other laboratory testing.

· Preliminary studies have shown that IL-6 levels are elevated in patients with severe COVID-19 and IL-6 may contribute to the severe inflammatory response, also sometimes referred to as cytokine storm.¹

· Elevated levels of IL-6 may be an early indicator that a patient is at risk of cytokine storm and acute respiratory distress ^2,3

^{_{1 https://www.immunology.ox.ac.uk/covid-19/literature-digest-old/the-potential-role-of-il-6-in-monitoring-severe-case-of-coronavirus-disease-2019}}

^{_{2 https://link.springer.com/article/10.1007/s00134-020-05991-x}} 

_{^{3 Maurizio, C at al. “Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection 4 Mehta P, McAuley DF}}